cardiovascular disease Archives

Diabetes: how to manage cardiovascular risk in secondary prevention patients

Sarah L Anderson, Joel C Marrs

Article Type

Review

Published

14 Jun 2022

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.

New and emerging lipid-modifying drugs to lower LDL cholesterol

Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, Evangelia J Papakonstantinou, Rogers Echavarria Uceta, Eliscer Guzman

Article Type

Review

Published

01 Nov 2021

This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.

Clinical potential of treatment with semaglutide in type 2 diabetes patients

Michael E Røder

Article Type

Review

Published

02 Dec 2019

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.

Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues

Ashutosh M Shukla MD, Aparna Wagle Shukla MD

Article Type

Review

Published

25 Nov 2019

This article reviews the expanding clinical applicability of chloroquine and related drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney disease (CKD), oncology, and a variety of nonmalarial infections.

Therapeutic management of hyperlipoproteinemia (a)

Constantine E Kosmas MD, PhD, Andreas Sourlas, Gordon Mallarkey PhD, Delia Silverio MD, Domingo Y Ynoa MD, Peter D Montan MD, Eliscer Guzman MD, Mario J Garcia MD

Article Type

Review

Published

04 Sep 2019

This review presents and discusses the current clinical and scientific data pertaining to the therapeutic options for the management of hyperlipoproteinemia (a).